+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hair Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Hair Diseases - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Growth Hormone Deficiency (GHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Growth Hormone Deficiency (GHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dry AMD - Pipeline Insight, 2025 - Product Thumbnail Image

Dry AMD - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Post-surgical Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Post-surgical Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Fibroblast Growth Factor Receptor 4 (FGFR4) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor Receptor 4 (FGFR4) Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 65 Pages
  • Global
From
Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
mGlu5 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

mGlu5 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PDE 10 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PDE 10 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Tau Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Tau Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Toll-like Receptor 4 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-like Receptor 4 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Toll-Like Receptor 8 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-Like Receptor 8 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Postpartum Hemorrhage - Pipeline Insight, 2025 - Product Thumbnail Image

Postpartum Hemorrhage - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lewy Body Dementia (LBD) - Pipeline Insight, 2025 - Product Thumbnail Image

Lewy Body Dementia (LBD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more